Keynote by Sangita Reddy Joint Managing Director Apollo Hospitals India AI Impact Summit
20 Feb 2026 16:00h - 17:00h
Keynote by Sangita Reddy Joint Managing Director Apollo Hospitals India AI Impact Summit
Summary
Dr. Pratap Siredi opened the talk by emphasizing that health care in India must be accessible regardless of zip code and that sustainable costs, preventive care, and early detection are essential to a new collaborative paradigm, leveraging the country’s large out-of-pocket market, expanding medical workforce, and extensive AI talent pool [1-4][8-9]. He described Apollo’s mission to bring advanced technology to patients, noting that the organization has integrated surgical robots, proton therapy, and a digital front door called Apollo 24-7 that lets users purchase medicines, order diagnostics, store records, and interact with an AI assistant [10-13].
Apollo 24-7 now serves over 45 million registered users with nearly one million daily interactions, and its services reach more than 1,100 towns and cities across India, extending beyond major urban centers [14-18]. The company’s AI platform, which has processed about 3.5 million API calls, is organized into five work streams that include a clinical intelligence engine, a decision-support system built on 20 million doctor records, disease-risk scoring for a 1.4 billion-person population, multimodal imaging analysis, and acute-care pathways that predict sepsis 24-48 hours in advance [19-24][25-32]. Additional AI capabilities aim to optimise throughput by automating billing, reducing patient wait times, and auto-populating records, with many tools already receiving MDSAP and FDA approvals [33-38].
To ensure responsible use, Apollo published the EASE framework, which addresses ethical adoption, suitability, and explainability of AI algorithms for health-care workers [40-43]. The speaker highlighted preventive initiatives such as an embedded-AI ultrasound that detects non-alcoholic fatty liver disease, a pre-diabetes algorithm already applied to 450 000 people, and collaborations with Google to identify tuberculosis from chest X-rays, all aimed at early disease interception [45-48][58-62][63-66]. A clinician-co-pilot tool that synthesises patient records is reported to save one to one-and-a-half hours of physician time per day, and a nurse-pilot version is being rolled out to further reduce workload [72-74].
Rural outreach includes mobile vans for non-communicable disease and cancer screening, tele-ophthalmology, and data sharing with ASHA workers and district health authorities to enable faster, cheaper diagnoses [79-82]. Apollo stresses that extensive validation-more than any other Indian health-care entity-is essential to move pilots into mainstream practice and to build trust among research, pharma, and manufacturing partners [83-85]. Looking ahead, the vision is an interconnected health system that links public and private sectors, primary and advanced care, research institutions, and health-tech startups, creating a flywheel that drives productivity, economics, and new predictive algorithms [86-93].
The speaker concluded by calling for collective action to close skill and regulatory gaps, make health care predictive, preventive, personalized, participatory, and place-agnostic, and to ensure every village, city, or apartment can access quality clinical care [94-99]. He ended with a hopeful note that this collaborative effort can accelerate cures for cancer and build a healthier future for the next generation [100].
Keypoints
Major discussion points
– A national AI-driven health-care ecosystem anchored in India’s unique advantages – the speaker highlights India’s large out-of-pocket market, rapid growth of doctors and nurses, and a talent pool of over 600,000 AI engineers as the foundation for a new, cost-effective, preventive-care paradigm that reaches every zip code [1-5][9-12][16-18].
– A multi-layered AI platform with concrete use-cases – Apollo has built five AI work streams (clinical intelligence engine, workforce analytics, disease-risk prediction, multimodal imaging & signal interpretation, and acute-care pathways). Examples include early-warning sepsis prediction 24-48 hours in advance, AI-assisted radiology for TB and brain bleed, and throughput optimisation that saves clinician time [19-35][30-34][38][64-66][72-74].
– Ethical, explainable AI governance – the “EASE” framework (Ethical, Adoption, Suitability, Explainability) is presented as a baseline for any health-care AI deployment, ensuring clinicians understand and trust algorithmic outputs [40-44].
– Preventive health and population-scale screening – AI tools for diabetes risk, NAFLD detection via ultrasound, and lifestyle risk scoring are being deployed at scale (e.g., 450 k users of a pre-diabetes algorithm). Mobile vans, tele-ophthalmology, and ASHA-worker integration extend these capabilities to rural India [44-62][80-82].
– Vision of an interconnected “health system of the future” – beyond hospital walls, the speaker calls for a unified network linking public and private sectors, primary and advanced care, research institutions, startups, and even drone logistics, to create a predictive, preventive, personalized, participatory, place-agnostic health ecosystem [85-92][95-98].
Overall purpose / goal
The speaker’s primary aim is to share Apollo Hospitals’ story of leveraging AI and digital tools to make high-quality health care affordable and accessible across India, demonstrate concrete innovations and their impact, and rally partners (researchers, pharma, tech firms, regulators) to collaborate in building a future health system that is preventive, data-driven, and universally reachable.
Overall tone
The discussion is consistently upbeat, confident, and visionary. It blends inspirational language (“a thousand flowers can bloom,” “let us dream of finding cures”) with detailed technical examples, maintaining an enthusiastic and persuasive tone throughout without noticeable shifts to a more somber or critical mood.
Speakers
– Speaker 1
– Name: Dr. Pratap Siredi
– Role/Title: Chairman, Apollo Hospitals (Apollo Group)
– Area of Expertise: Healthcare delivery, AI‑enabled health services, preventive and personalized medicine
Additional speakers:
– None identified
The talk opened with Dr Pratap Siredi, Chairman of Apollo Hospitals, who recalled that his father founded the first Apollo hospital after returning from the United States roughly 43 years ago, underscoring the family legacy that underpins the organisation’s mission [1-2]. He asserted that health-care in India must be a right that does not depend on the zip code of birth, emphasizing sustainable costs, preventive care and early detection as the foundation of a new collaborative paradigm [3-5].
He then outlined India’s systemic advantages: a large out-of-pocket payment market, rapid expansion of doctors and nurses, and a talent pool of more than 600 000 AI engineers that together provide the scale and affordability needed to build a national, AI-driven health-care ecosystem [6-9][10-12].
To operationalise this vision, Apollo has created a digital front-door called Apollo 24-7, an integrated patient portal where users can purchase medicines, order diagnostics, store health records and interact with an AI assistant (Apollo Assist) [13-15]. The platform now hosts over 45 million registered users and sees close to one million daily interactions, demonstrating strong market adoption and scalability [16-18].
Underlying Apollo 24-7 is a multi-layered AI platform organised into five work streams [19-20].
1. Clinical intelligence engine – supplies new doctors with the collective knowledge of 20 million clinician records, forming a robust decision-support system [21-23].
2. Disease-risk prediction – generates population-level risk scores for a 1.4-billion-person cohort, targeting cardiac disease, diabetes and hypertension [24-26].
3. Multimodal imaging & signal analytics – extracts insights from imaging and physiological data, synthesising information more effectively than any single clinician [27-28].
4. Acute-care pathways – includes an early-warning system that predicts sepsis 24-48 hours before onset across 2 000 critical-care beds, with the speaker noting the potential impact of scaling to 100 000 ICU beds [29-33].
5. Throughput optimisation – automates billing, reduces patient wait times and auto-populates records, thereby freeing clinician capacity [34-36].
Regulatory progress is substantial, with approximately 19 tools receiving MDSAP approval and nine securing FDA clearance, underscoring the emphasis on safety and efficacy [37-38]. Following this, the speaker invited collaborators, stating “we’re looking for partnership to build because I believe in this space” [39].
He introduced the EASE framework – Ethical, Adoption, Suitability, Explainability – as a baseline governance model to ensure AI deployments are transparent, appropriate for the clinical context and understandable to health-care workers [40-43].
Preventive-care initiatives were highlighted. An embedded-AI module in ultrasound machines can detect non-alcoholic fatty liver disease (NAFLD) early, potentially averting liver transplantation for millions [44-46]. A pre-diabetes AI product, already applied to 450 000 individuals, is envisioned to scale to the estimated 85 million diabetics in India [47-51]. Lifestyle-risk scoring tools, developed with Solventum and 3M, quantify risk profiles and guide personalised interventions, moving beyond generic social-media health advice [52-57]. The speaker quantified the preventive impact, noting that screening 1 000 people averts major crises in 11 of them [58-59].
In radiology, collaborations with Google enable AI-based tuberculosis detection from chest X-rays, while other partners support rapid identification of brain bleeds, facilitating swift emergency care [60-63].
The clinician co-pilot synthesises patient records, saving physicians 1-1.5 hours per day [64-66]; a parallel nurse pilot will extend these time-saving benefits to nursing staff [67-68].
Acute-care monitoring is further advanced through the Care Console, which integrates ICU and home-ward data, and the envisioned use of drone delivery to transport medicines and diagnostics as part of the “hospital of the future” concept [69-71].
Rural outreach forms a critical pillar of the strategy. Mobile vans conduct non-communicable disease and cancer screening, tele-ophthalmology services reach remote populations, and data are shared with ASHA workers and district health authorities to enable faster, cheaper diagnoses [72-74].
Apollo positions itself as one of India’s most active validators of AI pilots, recognising that rigorous validation is essential to transition innovations from proof-of-concept to mainstream practice [75-77].
Looking ahead, the speaker reframed the “hospital of the future” as an interconnected health system linking public and private providers, primary and advanced care, research institutions, universities and health-tech startups [78-82]. He described this network as a “flywheel” that drives productivity, economic sustainability and the development of new predictive and preventive algorithms [83-84]. The vision is a health ecosystem that is predictive, preventive, personalised, participatory and place-agnostic, capable of delivering high-quality care to any village, city or apartment [85-89].
In conclusion, the speaker called for collective action to close skill gaps, accelerate regulatory pathways and unite companies, organisations and individuals in building this new health-care world [90-92]. He urged that every community, regardless of location, should have access to good clinical care and expressed optimism that such collaboration could hasten cures for cancer and secure a healthier future for the next generation [93-95].
India and that your health care should not be defined by the zip code in which you’re born. It’s about sustainable costs and it’s about preventive care and early detection. It’s a new paradigm in collaborative care where I believe India has an advantage. This advantage is because we not only have one of the highest out -of -pocket payment and therefore we’re creating innovation and keeping our costs low, but also we’re growing more doctors, we’re training more nurses, and we have the largest talent pool of over 600 ,000 AI engineers. All this coming together to create something truly significant. But I’m not here to talk to you about technology. I’m here to share our story. And this story is about using the passion and the mission of bringing health care within the reach of people and using every tool possible to enable this to happen.
Dr. Pratap Siredi. I’m the art chairman and I’m honored to say my father. brought to polar hospitals when he returned from the U .S. almost 43 years ago to bring this, to bring healthcare within the reach of people. Today, we’ve tried to embed and imbibe every technology, whether it’s surgical robots, the proton therapy, all kinds of treatment and curative capability. We’ve gone beyond to say we must find a way to not just use these machines, but also to connect with our customer. So Apollo 24 -7, our digital front door, is actually, not only can you buy your medicines, order your diagnostics, store your health record, but also on Apollo Assist, ask queries, questions, get these answered, and then find ways.
And our market has rewarded us with the volumes that we see. Over 45 million users have come into this. and now we have close to a million users on a daily basis coming in to interact on this ecosystem. These records, these capabilities are getting enhanced every day because of the power of the communications that we have. But moving on, I think what is most important is that we’re not just in the big cities. We’re serving multiple PIN codes across the country and over 1 ,100 towns and cities. Moving across divine methodologies, I just wanted to share with you quickly a few of the things that we’re doing in AI because this is the AI summit. And approximately now we have about 3 .5 million API calls on our AI platforms.
These platforms we’ve divided into five areas. Number one is really our clinical intelligence engine so that a new doctor can have the knowledge and the capability of the cumulative data that we’re providing to the patient. And number two is the cumulative doctor workforce of about 20 million records analyzed. So this is our clinical decision support and our clinical intelligence engine. The next one is the disease prediction and the risk score, because we need to know in a population of 1 .4 billion people, where do we focus? What should we do more? So this is the second work stream, and this goes across cardiac, diabetes, multiple others, including hypertension, but we’re also looking at embedded AI. The next and another critical one is taking images and signals, because the body is an amazing piece of machinery that continues to give us this messaging.
How do we pick this up, synthesize it smarter than any one individual can do, and bring this multimodal signaling into a causal interpretation to thereby enable the doctor. We also have acute care augmented pathways. About 2 ,000 of our critical care beds are connected with our early warning symptom, and there we are predicting. The onset of sepsis. 24 to 48 hours before it happens. Imagine if we could take this AI algorithm and put it into a hundred thousand ICU beds. Imagine the number of lives saved. So here I’m sharing these examples because I believe that the power of AI is directly proportionate to the impact that we can have on lives saved, disease prevented, cost reduction, and therefore talking about cost reduction, the final one is really throughput optimization.
How can you be smarter about billing? How can you ensure that your patient has zero waiting time, that the data capture is using ambient systems, therefore the doctor is able to look at the patient and talk to the patient and you’re doing auto -population of your records. Millions of these capabilities are coming together. We’ve collated them. We’re getting MDSAP approval on almost 19 of them, FDA approval for nine, and we’re looking for partnership to build because I believe in this space. a thousand flowers can bloom, and that there is deeper work to be done on the use of our blood bank and our biobank with genetic testing to move further into disease prediction, biomarkers. So these are just new dimensions opening up.
And I’m sharing more of the examples of how we’re working in these areas, but before I go into those, I want to talk about the EASE framework. I’m happy that our EASE framework has been published fairly extensively because it talks about the ethical considerations of the use of AI. It looks at adoption, the suitability of a certain algorithm within the area that it’s being used, and finally the explainability so that every healthcare worker is able to understand what they use in which environment and what the interpretation means. I believe this is a base framework that we need to put into every healthcare environment. Moving on is another area of deep passion, and that is that while we’re doing the highest end of surgeries, curative care, transplants, etc.
How much can we spend our time on health care prevention? Because for every life -saving intervention, for every 1 ,000 people screened, you will have 11 people where you have averted a major crisis. And therefore, the ability to look at proactive preventive care and get a lot more intuitive on the mechanism of biomarkers and early detection in cancer. We are working with the ultrasound company to do an embedded AI into the ultrasound machine so that we can pick up NAFLD, non -alcoholic fatty liver, of which 40 % of the adult population of India is susceptible to. And if you can pick it up early, you can completely prevent a major crisis if you find it late. These are candidates for liver transplant, a lot of pain and suffering, and some of them potential death.
So the interventions at the appropriate time using technology open up an entire… realm of what we can do differently in this world. I’m sharing now this aspect of how lifestyle changes risk reduction. All of you on Instagram are getting thousands of messages a day on what to eat, how to exercise, what to do better. But is it quantified? Is there a risk scoring? Do you understand the difference between a high -risk group and what they need to do to a low -risk group? But every single group, by understanding the risk profiling and the modifiable risk factors of these non -communicable disease can move into a healthy pattern. This has been studied in partnership with Solventum, the company with 3M, with definitive proof on the power of doing something like this.
We also have a significant product on AI prediabetes which I think we’ve used for a long time. We’ve used it for a long time. We’ve used it for a long time. We’ve used this algorithm over 450 ,000 people. But I would love to see the 85 million diabetics in our country using this to predict and to handle their diabetes better. I also want to move on to the fact that in radiology, because of the years of data and the teleradiology services that we do across the world, we are able to take these images, and here we’ve worked with Google on prediction of tuberculosis in a simple x -ray. We’re working with various other companies, whether it’s an early detection of a brain bleed.
So once somebody goes into the emergency room, you’re quickly able to diagnose these. Each one of these are amazing new factors which are coming in. This is a quick example of the clinician co -pilot. Because I’m running out of time, I’m not going to share this video, but basically… Okay, they are playing the video. Can we have some volume on this? Or I’ll click through, because we’re really running out of time. But basically what the clinician co -pilot does is it’s synthesizing the record so that you’re summarizing. We’re approximately saving… We’re saving one to one and a half hours per day of doctor time in the records. We’re now doing the nurse pilot. I’m moving now to reimagining the way patients are monitored, whether it’s the challenge of a misdiagnosis, the integrated solution, which is looking at Care Console, and the technology stack around this, which is connecting the command station with the ICUs, with home, and with connected wards.
And because of this, we’ve not only saved millions of lives, we’ve saved time for doctors, and this is connected even to external nursing homes in small rural areas. I believe this is a powerful solution where the current AI algorithm has multiple factors from antibiotic usage to early warning symptoms of sepsis, but there are potentially another hundred algorithms that we could add on to this to enhance the quality of decision -making. And share this further, enabling a safer patient care and also less burnout in our staff. I’ve been sharing lots of hospital -based examples, but I do want to say that many of the solutions are applicable in rural India. We’re running mobile vans, we’re doing non -communicable disease screening in small rural environments, we’re finding ways to do cancer screening, tele -ophthalmology screening, and sharing this data and enabling either the ASHA worker or the district health authorities or even the government hospitals to diagnose faster, better, cheaper, and earlier.
And this is really the power of what can be done through early screening. I also do want to say, because for those who are listening from research organizations, from pharmaceuticals, from manufacturing, that we are among the people doing the largest number of validations. So innovation happens from multiple quarters, but validation is what moves a pilot into a mainstream activity. And that is what is critical for our country because you’ve been hearing this over the last two days about the number of pilots happening, but we’re not finding ways to continue this. I believe the hospital of the future is interconnected in multiple ways, from the theatres to the ICUs to using drone delivery. But then as we were drawing and designing this, we actually said, no, our thinking is too small and narrow.
We need to think bigger because the world is more connected. And primary care, preventive care, out there in the market, home care, these are the important redefinition factors of the future of healthcare. And so now I talk not about hospitals of the future, but about health systems of the future. This is what we need to redefine, and we have to do this together. These health systems of the future connect public and private, connect primary care with advanced care, connect research institutions, universities, innovators, health tech startups, all together to build new solutions for the betterment of healthcare. And I believe that this is a flywheel which will drive not just positive health productivity and the economics of the healthcare environment, but this data will enhance into new algorithms.
And these algorithms can be predictive and preventive, and if you find disease earlier, you’re actually saving so many aspects. So let us remove skill gaps. Let us push through regulatory gaps. Let us bring companies, organizations, and people together to build a new healthcare world, which is predictive, preventive, personalized, participatory, and place agnostic. Let every village in any part of the world, or every city, or every apartment building, wherever you are, be able to access good clinical care. Let’s come together to build a healthier world. And definitely, let’s say that this is the time for us to… to dream of finding cures for cancer, of enabling the world to be healthier, and finding a methodology for us to say that we brought our next generation into a healthier world.
Thank you so much, and namaste. Thank you. Thank you.
Dr. Reddy argues that India’s healthcare system has structural advantages that position it well for innovation. The high out-of-pocket payments create pressure for cost-effective solutions, while the …
EventThis comment energized the discussion by providing a grand vision that contextualized all the individual innovations within a larger national transformation narrative. It shifted from individual succe…
EventBagla articulated a compelling vision of India’s unique advantages in the global AI landscape, asserting that India will be “the biggest benefactor of AI as a delta multiplier.” This is grounded in th…
EventAnd approximately now we have about 3 .5 million API calls on our AI platforms. These platforms we’ve divided into five areas. Number one is really our clinical intelligence engine so that a new docto…
EventAlgorithmic transparency is a critical topic discussed in various sessions, notably in the9821st meetingof the AI Security Council. During these discussions, experts emphasized the necessity of rigoro…
EventEven if the Act itself does not make direct reference to “ethics”, it is closely tied to the broader context of ethical guidelines established by the EU, known as theEU Ethics Guidelines for Trustwort…
BlogChris Martin: Thanks, Ahmed. Well, everyone, I’ll walk through I think a little bit of this presentation here on what DCO’s view is on ethical AI governance. And then my colleague, Matt Sharp, w…
EventDiscussion point:Cost Reduction and Efficiency in Healthcare Delivery Discussion point:Preventive Healthcare and Population-Scale Programs
EventThe speech concluded with a critical reflection on the urgent necessity to tackle health-related misinformation, a matter of life-and-death significance where fallacies can lead to fatal health risks….
EventAmanuel Giorgio : Thank you, Co-Chairs. In an era marked by unprecedented global challenges, the need for collective action and cooperation has never been more urgent. Escalating conflict and risi…
Event“Dr Pratap Siredi recalled that his father founded the first Apollo hospital after returning from the United States roughly 43 years ago.”
The knowledge base notes that Dr Pratap Siredi mentioned his father brought Apollo Hospitals back from the U.S. almost 43 years ago, confirming the timeline and founder relationship [S14].
“India has a talent pool of more than 600 000 AI engineers that together provide the scale and affordability needed to build a national, AI‑driven health‑care ecosystem.”
A source reports that India employs over 600 000 engineers, highlighting the size of the technical workforce that can support large-scale AI initiatives [S37].
“India’s systemic advantages include a large out‑of‑pocket payment market, rapid expansion of doctors and nurses, and a talent pool of more than 600 000 AI engineers.”
Beyond the engineer count, the knowledge base emphasizes India’s status as a strong AI growth market and its large engineering graduate output, providing broader context for the country’s systemic advantages for AI deployment [S37] and [S38].
“He introduced the EASE framework – Ethical, Adoption, Suitability, Explainability – as a baseline governance model for AI deployments.”
The EASE framework is explicitly referenced in the knowledge base as a published model covering ethical considerations, adoption, suitability and explainability of AI in health-care [S35].
The transcript contains remarks from a single participant (Speaker 1) who presents a cohesive set of arguments about AI‑enabled healthcare in India. Because no other speakers are present, there are no cross‑speaker agreement points, shared viewpoints, or surprising consensuses to report.
No multi‑speaker consensus can be assessed; the discussion reflects a single perspective that is internally consistent but does not reveal agreement or divergence among multiple participants.
The transcript contains only statements from Speaker 1, with no other participants presenting contrasting views. Consequently, there are no identifiable points of disagreement, partial agreement, or unexpected disagreement within the discussion.
No disagreement detected; the discussion reflects a single perspective, implying consensus or lack of debate on the presented topics.
Speaker 1’s monologue weaves together data, personal story, and visionary concepts, using a series of strategically placed insights that repeatedly shift the conversation’s focus—from equity and talent, to digital platforms, to AI‑driven clinical intelligence, to life‑saving predictive models, to ethical governance, and finally to a holistic, interconnected health‑system vision. Each pivotal comment not only introduced a fresh dimension but also redirected audience attention, deepening the analysis and building momentum toward a call for collaborative, system‑wide transformation. Collectively, these moments shaped the discussion from a descriptive showcase of technology into a compelling narrative about how AI, when ethically grounded and broadly deployed, can redefine health care for all of India and beyond.
Disclaimer: This is not an official session record. DiploAI generates these resources from audiovisual recordings, and they are presented as-is, including potential errors. Due to logistical challenges, such as discrepancies in audio/video or transcripts, names may be misspelled. We strive for accuracy to the best of our ability.
Related event

